Inhibition of glycogen synthase kinase 3 increased subventricular zone stem cells proliferation

Narges Pachenari1, Sahar Kiani2, Mohammad Javan3

  • 1Department of Physiology, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Insights

Glycogen Synthase Kinase 3 (GSk-3) inhibition with CHIR99021 enhances subventricular zone (SVZ) progenitor proliferation in vitro and in vivo. This effect is long-lasting and particularly pronounced following neural insult, suggesting therapeutic potential.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Regenerative Medicine

Background:

  • Subventricular zone (SVZ) progenitor proliferation is crucial for neural repair.
  • Wnt signaling pathway modifiers can influence cell proliferation in a cell-specific manner.
  • Glycogen Synthase Kinase 3 (GSk-3) is a key regulator in cellular signaling pathways.

Purpose of the Study:

  • To investigate the effect of CHIR99021, a GSk-3 inhibitor, on SVZ progenitor proliferation.
  • To assess the in vitro and in vivo impact of CHIR99021 on neural stem cells.
  • To determine if CHIR99021 enhances progenitor proliferation following induced neural insult.

Main Methods:

  • Neural stem cells were isolated and cultured from adult C57bl/6 mice.
  • Cells were treated with varying concentrations of CHIR99021 or vehicle.
  • In vivo studies involved intracerebroventricular (i.c.v.) CHIR99021 administration, with a subgroup receiving intranasal kainic acid.
  • Sphere formation, size, and progenitor cell counts were assessed.

Main Results:

  • CHIR99021 significantly increased SVZ progenitor proliferation in vitro, with a sustained effect even after drug removal.
  • In vivo administration of CHIR99021 boosted neural progenitor numbers in the lateral ventricles.
  • Combined CHIR99021 treatment and kainic acid-induced neurodegeneration led to a notable increase in progenitor cells.

Conclusions:

  • Inhibition of GSk-3 by CHIR99021 is an effective method to enhance SVZ progenitor proliferation.
  • CHIR99021 demonstrates potential for promoting neural regeneration, especially in contexts of neural injury.
  • The findings support the role of GSk-3 inhibition in boosting endogenous neural repair mechanisms.